Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Collagenase and elastase are two distinct classes of proteolytic enzymes that play synergistic roles in the degradation and remodeling of the extracellular matrix (ECM) [8, 11]. Collagenases, primarily members of the matrix metalloproteinase (MMP) family or bacterial enzymes, specifically cleave the triple-helical structure of native collagen, while elastases (including serine proteases like neutrophil elastase and certain MMPs) target elastin fibers [5, 14]. Together, these enzymes are critical for physiological processes such as wound healing, tissue dissociation, and embryonic development [9, 10]. However, their overactivation is a hallmark of various pathological conditions, including skin photoaging, chronic obstructive pulmonary disease (COPD), and cancer metastasis, where they facilitate tissue destruction and cellular invasion [2, 6, 12]. In the pharmaceutical and cosmetic industries, these enzymes are frequently targeted together, particularly in anti-aging formulations where natural polyphenols like EGCG or synthetic inhibitors are used to preserve skin elasticity and structural integrity [4, 13]. Conversely, purified collagenase and elastase blends are utilized therapeutically and in laboratory settings for tissue dissociation and the treatment of fibroproliferative disorders like Dupuytren's contracture [1, 8]. The term 'Collagenase/Elastase' is considered incorrect as a single target because it represents a functional grouping of two separate enzyme types rather than a single molecular entity.
Inhibition of proteolytic activity to prevent extracellular matrix degradation; enzymatic hydrolysis of pathological collagen deposits; competitive and non-competitive inhibition of enzyme active sites.
8 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Collagenase and Elastase.